テロメラーゼRNA要素
関連文献

“For better or worse? Telomerase inhibition and cancer”. Cell 98 (3):  273–5. (August 1999). doi:10.1016/S0092-8674(00)81955-8. PMID 10458601.
“Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer”. Expert Reviews in Molecular Medicine 6 (26):  1–23. (December 2004). doi:10.1017/S1462399404008671. PMID 15613268.
“Mutations of telomerase complex genes linked to bone marrow failures”. Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi 74 (3):  202–9. (June 2007). doi:10.1272/jnms.74.202. PMID 17625368.
“Method for determining RNA 3' ends and application to human telomerase RNA”. Nucleic Acids Research 24 (3):  532–3. (February 1996). doi:10.1093/nar/24.3.532. PMC 145649. PMID 8602368. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC145649/.
“Mapping of the gene for the mouse telomerase RNA component, Terc, to chromosome 3 by fluorescence in situ hybridization and mouse chromosome painting”. Genomics 41 (2):  293–4. (April 1997). doi:10.1006/geno.1997.4621. PMID 9143511.
“Cloning and characterization of human and mouse telomerase RNA gene promoter sequences”. Oncogene 16 (10):  1345–50. (March 1998). doi:10.1038/sj.onc.1201892. PMID 9546436.
“A telomerase component is defective in the human disease dyskeratosis congenita”. Nature 402 (6761):  551–5. (December 1999). Bibcode: 1999Natur.402..551M. doi:10.1038/990141. PMID 10591218.
“Secondary structure of vertebrate telomerase RNA”. Cell 100 (5):  503–14. (March 2000). doi:10.1016/S0092-8674(00)80687-X. PMID 10721988.
“Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation”. Nature Genetics 26 (1):  85–8. (September 2000). doi:10.1038/79232. PMID 10973255.
“Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase”. Molecular Cell 6 (2):  361–71. (August 2000). doi:10.1016/S1097-2765(00)00036-8. PMID 10983983.
“SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus”. Biochemical and Biophysical Research Communications 286 (3):  559–65. (August 2001). doi:10.1006/bbrc.2001.5428. PMID 11511096.
“The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita”. Nature 413 (6854):  432–5. (September 2001). Bibcode: 2001Natur.413..432V. doi:10.1038/35096585. PMID 11574891.
“Allosteric inhibitors of telomerase: oligonucleotide N3'-->P5' phosphoramidates”. Nucleic Acids Research 30 (2):  559–68. (January 2002). doi:10.1093/nar/30.2.559. PMC 99832. PMID 11788719. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC99832/.
“Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells”. Cell Research 12 (1):  55–62. (March 2002). doi:10.1038/sj.cr.7290110. PMID 11942411.
“Nucleolar localization of hTERT protein is associated with telomerase function”. Experimental Cell Research 277 (2):  201–9. (July 2002). doi:10.1006/excr.2002.5541. PMID 12083802.
“Differential regulation of telomerase activity by six telomerase subunits”. European Journal of Biochemistry 269 (14):  3442–50. (July 2002). doi:10.1046/j.1432-1033.2002.03025.x. PMID 12135483.
“Minimum length requirement of the alignment domain of human telomerase RNA to sustain catalytic activity in vitro”. Nucleic Acids Research 30 (20):  4470–80. (October 2002). doi:10.1093/nar/gkf575. PMC 137139. PMID 12384594. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137139/.
“p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma”. Cancer Biology & Therapy 1 (5):  511–7. (2003). doi:10.4161/cbt.1.5.167. PMID 12496479.
“Analysis of the structure of human telomerase RNA in vivo”. Nucleic Acids Research 30 (4):  912–20. (February 2002). doi:10.1093/nar/30.4.912. PMC 100349. PMID 11842102. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC100349/.
hTRと結合するテロメラーゼ複合体タンパク質